Intestinal Microbiota Is Altered in Patients with Gastric Cancer from Shanxi Province, ChinaOriginal paper
Karen Pendergrass is a microbiome researcher specializing in microbiome-targeted interventions (MBTIs). She systematically analyzes scientific literature to identify microbial patterns, develop hypotheses, and validate interventions. As the founder of the Microbiome Signatures Database, she bridges microbiome research with clinical practice. In 2012, based on her own investigative research, she became the first documented case of FMT for Celiac Disease, four years before the first published case study.
Read MoreWhat was studied?
This study investigated the composition of the intestinal (gut) microbiota in patients with gastric cancer compared with healthy individuals. The researchers used 16S rRNA gene sequencing on fecal samples to characterize microbial community differences. They also examined correlations between the intestinal microbiota and cellular immunity, including peripheral T lymphocyte subpopulations and NK cells, measured by flow cytometry.
Who was studied?
The study included 116 gastric cancer patients and 88 healthy controls from Shanxi Province, China, who provided fecal samples for microbiota analysis. A subset of this group, 66 gastric cancer patients and 46 healthy controls, also provided peripheral blood samples for immune cell profiling. All participants were drawn from a single geographic region in China.
What were the most important findings?
Gastric cancer patients showed increased intestinal species richness compared with healthy controls. Butyrate-producing bacteria were decreased, while other symbiotic bacteria were enriched, particularly Lactobacillus, Escherichia, and Klebsiella. Lactobacillus and Lachnospira emerged as key species within the network of gastric cancer associated bacterial genera, and a combination of five genera, Lachnospira, Lactobacillus, Streptococcus, Veillonella, and Tyzzerella_3, performed well in distinguishing gastric cancer patients from controls based on the information provided.
What are the greatest implications of this study?
These findings suggest that gastric cancer is associated with a distinct pattern of intestinal dysbiosis, marked by loss of butyrate producers and enrichment of specific symbiotic genera. The identified microbial signature, especially the five-genus combination, points toward potential use of gut microbiota profiling as a non-invasive tool to help distinguish gastric cancer patients from healthy individuals. The proposed links to cellular immunity also support the broader concept that host-microbial interactions may influence immune regulation relevant to gastric cancer development.